Validation of a Kinetic Model of Erlotinib
NCT02904850
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
BIOLOGICAL:
group of patients
Sponsor
University Hospital, Strasbourg, France